BC
Brian Cheng JP Morgan Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
23
Avg Return
Past Year
Past Year
30%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
66.7%
Neutral
16.7%
Negative
16.7%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $125 |
80%
upside
| 1 | -20% |
0
%
| 10 Dec ‘25 1 month ago |
|
|
|
Neutral
Initiated
| – | – | 1 | – |
–
| 20 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $81 |
1%
downside
| 1 | +38% |
0
%
| 7 Nov ‘25 2 months ago |
|
|
|
Underweight
Downgraded
| $5 |
60%
downside
| 1 | -1.5% |
0
%
| 7 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $18 |
41%
upside
| 1 | -11% |
0
%
| 6 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $82 |
32%
downside
| 1 | +103% |
0
%
| 6 Nov ‘25 2 months ago |
|